Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China · Delayed Price · Currency is CNY 11.48
-0.16 (-1.37%)
Mar 20, 2026, 3:00 PM CST
SHA:603811 Market Cap
SHA:603811 has a market cap or net worth of 3.65 billion as of March 20, 2026. Its market cap has increased by 40.51% in one year.
Market Cap
3.65B
Enterprise Value
3.57B
Revenue
790.86M
Ranking
n/a
PE Ratio
16.38
Stock Price
11.48
Market Cap Chart
Since March 15, 2017, SHA:603811's market cap has increased from 1.93B to 3.65B, an increase of 88.66%. That is a compound annual growth rate of 7.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.65B | 9.33% |
| Dec 31, 2025 | 3.34B | 32.01% |
| Dec 31, 2024 | 2.53B | -25.55% |
| Dec 29, 2023 | 3.39B | 3.77% |
| Dec 30, 2022 | 3.27B | -13.80% |
| Dec 31, 2021 | 3.79B | -1.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai MicuRx Pharmaceutical | 4.11B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 4.08B |
| Honz Pharmaceutical | 3.97B |
| Tibet AIM Pharm. | 3.97B |
| Huaren Pharmaceutical | 3.87B |
| Shandong Wohua Pharmaceutical | 3.86B |
| Harbin Medisan Pharmaceutical | 3.74B |
| Tuoxin Pharmaceutical Group | 3.63B |